All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Does testosterone actually fix low libido in women?

Sophia Rudy

TikTok creator

4.7M viewsWatch on TikTok→

Quick answer

This video addresses hypoactive sexual desire in women, with the creator attributing her low libido primarily to prolonged combined oral contraceptive use, which can suppress free testosterone through increased sex hormone-binding globulin (SHBG). Her three-year post-pill recovery arc is consistent with some documented cases of persistent SHBG elevation, though the timeline is highly individual and not benchmarked in clinical literature. Women with persistent low libido after hormonal contraceptive discontinuation should be evaluated for androgen insufficiency, thyroid dysfunction, and mood disorders before assuming spontaneous resolution.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does testosterone actually fix low libido in women?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Does testosterone actually fix low libido in women? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Does testosterone actually fix low libido in women?" from Sophia Rudy. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video addresses hypoactive sexual desire in women, with the creator attributing her low libido primarily to prolonged combined oral contraceptive use, which can suppress free testosterone through increased sex hormone-binding globulin (SHBG).

The reason this review is not generic is the source wording and the canonical claim label "trt things i ve done to help my libido lowlibido libido lowlibid." In this clip, the useful excerpt is: "As someone who has been dating their boyfriend for almost five years, has lived with them for over two and a half, and has been somebody who has struggled with low sex drive or no sex drive as a young woman, I'm gonna give you guys my best..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 2006 study (Panzer et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video addresses hypoactive sexual desire in women, with the creator attributing her low libido primarily to prolonged combined oral contraceptive use, which can suppress free testosterone through increased sex hormone-binding globulin (SHBG).

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video addresses hypoactive sexual desire in women, with the creator attributing her low libido primarily to prolonged combined oral contraceptive use, which can suppress free testosterone through increased sex hormone-binding globulin (SHBG). Her three-year post-pill recovery arc is consistent with some documented cases of persistent SHBG elevation, though the timeline is highly individual and not benchmarked in clinical literature. Women with persistent low libido after hormonal contraceptive discontinuation should be evaluated for androgen insufficiency, thyroid dysfunction, and mood disorders before assuming spontaneous resolution.
  • A 2013 Journal of Sexual Medicine review (Burrows et al.) confirmed that combined oral contraceptives reduce libido in a measurable subset of users, primarily through SHBG-mediated suppression of free testosterone.
  • A 2006 study (Panzer et al., Journal of Sexual Medicine) found SHBG levels remained elevated in some women four to six months after stopping the pill, meaning discontinuation does not immediately reverse the hormonal effect.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2013 Journal of Sexual Medicine review (Burrows et al.) confirmed that combined oral contraceptives reduce libido in a measurable subset of users, primarily through SHBG-mediated suppression of free testosterone.
  • A 2006 study (Panzer et al., Journal of Sexual Medicine) found SHBG levels remained elevated in some women four to six months after stopping the pill, meaning discontinuation does not immediately reverse the hormonal effect.
  • Sexual desire fluctuates across the menstrual cycle, peaking in the follicular and ovulatory phases, a pattern supported by multiple studies and not just cycle-tracking influencer content.
  • Progesterone is associated with reduced libido in the luteal phase, but the mechanism involves multiple hormones, and individual variation is large enough that some women report no change or the opposite effect.
  • Persistent low libido after stopping hormonal contraceptives warrants clinical evaluation for androgen insufficiency, thyroid dysfunction, and depression, rather than an indefinite waiting period.
  • The 2019 Global Consensus Position Statement (Davis et al., Journal of Clinical Endocrinology and Metabolism) supports testosterone therapy for hypoactive sexual desire disorder in select women, but this is an off-label clinical decision, not a self-managed one.
  • Communication and anticipation strategies in long-term relationships, such as signaling intent earlier in the day, align with behavioral research on desire in partnered contexts, where spontaneous desire often shifts to responsive desire over time (Basson, 2001, Journal of Sex and Marital Therapy).

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @sophiaarudy actually say?

Sophia made several specific claims worth examining. She said that being on hormonal birth control for seven to eight years caused her low libido, and that stopping it three years ago started her recovery. She claimed that progesterone rising in the luteal phase is "the libido killer." She also said that scheduling sex, reading romance novels, listening to graphic audio content, and removing pornography from her relationship all helped restore her sex drive. These are a mix of personal anecdotes and biological claims, and they deserve different levels of scrutiny.

To her credit, she was careful to say "for me" and "this isn't for everyone" at multiple points. That kind of epistemic humility is rare in TikTok health content. Still, when you have 4.7 million views, your personal experience gets read as advice, whether you intend it to or not.

Does the science back this up?

Mostly, yes, with some important nuance. The hormonal birth control and libido connection is real and documented. The luteal phase claim is broadly supported. The cycle-tracking piece is solid. Where things get shakier is in the implied causal certainty and the three-year recovery timeline, which has no real benchmarking in the literature.

On hormonal contraceptives and libido: a 2013 study by Burrows et al. in the Journal of Sexual Medicine found that combined oral contraceptives can reduce sexual desire in a subset of users, partly through suppression of testosterone and increases in sex hormone-binding globulin (SHBG). SHBG binds free testosterone, which is one mechanism that matters for libido in women. Importantly, SHBG can remain elevated even after stopping the pill, sometimes for months. Whether it returns to baseline, and how quickly, varies substantially by individual. A 2006 study by Panzer et al. in the Journal of Sexual Medicine found SHBG levels remained elevated in some women even four to six months post-discontinuation.

On the luteal phase and progesterone: the claim holds up reasonably well. van Anders et al. (2005, Hormones and Behavior) and broader reproductive endocrinology research support the general finding that sexual desire tends to peak around ovulation and decline in the late luteal phase. However, the mechanisms are not purely about progesterone being a "killer." Testosterone levels also fluctuate across the cycle, and the interplay is more complex than one hormone doing the damage.

What did they get wrong (or right)?

She got the big picture right. Hormonal contraceptives can suppress libido in some women. Cycle-phase differences in desire are real. Scheduling intimacy and communication in long-term relationships is backed by relationship research, not just intuition. Removing stimuli that create unrealistic expectations has psychological logic behind it.

Where she oversimplifies: calling progesterone flatly "the libido killer" ignores that some women report no change or even increased desire in the luteal phase. Individual variation here is enormous. She also implies a clean before-and-after arc, that stopping birth control eventually fixes the problem, without acknowledging that for some women, post-pill libido issues persist or have other causes entirely, including thyroid dysfunction, depression, relationship dynamics, or androgen insufficiency that exists independent of contraceptive use.

The pornography claims are largely unverifiable in this context. There is research on pornography and relationship satisfaction (Wright et al., 2017, Computers in Human Behavior), but her specific claim that removing it helped her libido is personal experience, not a generalizable prescription. To her credit, she frames it that way.

What should you actually know?

If you stopped hormonal birth control and your libido still has not returned after several months, that is worth a conversation with a clinician, not just more patience. Low libido in women has multiple possible drivers, and "I stopped the pill" does not automatically reset the system. Testing for free testosterone, SHBG, thyroid function, and ruling out depression is reasonable first-line workup.

Testosterone therapy for women with documented androgen insufficiency is an area of active clinical interest, though it remains off-label in the U.S. The Global Consensus Position Statement on testosterone use in women (Davis et al., 2019, Journal of Clinical Endocrinology and Metabolism) supports its use for hypoactive sexual desire disorder in specific populations, with appropriate monitoring. That is a clinical conversation, not a TikTok one.

The cycle-syncing piece she mentions is genuinely useful as self-awareness, but it should not be used to pathologize normal variation. Desire that fluctuates across the month is biology, not dysfunction.

  • Not all libido loss after stopping hormonal birth control resolves on its own or on any predictable timeline.
  • Elevated SHBG post-pill can persist for months and suppress available testosterone even after discontinuation.
  • Progesterone's role in libido suppression is real but not the whole story. Cycle-phase variation involves multiple hormones.
  • Communication and anticipation strategies in long-term relationships are supported by behavioral research, not just anecdote.
  • Persistent low libido after ruling out contraceptive causes warrants clinical evaluation, not just lifestyle changes.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Sophia Rudy · TikTok creator

4.7M views on this video

things I’ve done to help my libido🫶🏼 #lowlibido #libido #lowlibidowomen #romance #romancebooks #intimacy #intimacytip #intimacyideas #longtermrelationship #relationshipadvice

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the evidence say about a 2013 journal of sexual medicine review (burrows et al.)?

A 2013 Journal of Sexual Medicine review (Burrows et al.) confirmed that combined oral contraceptives reduce libido in a measurable subset of users, primarily through SHBG-mediated suppression of free testosterone.

What does the evidence say about a 2006 study (panzer et al., journal of sexual medicine)?

A 2006 study (Panzer et al., Journal of Sexual Medicine) found SHBG levels remained elevated in some women four to six months after stopping the pill, meaning discontinuation does not immediately reverse the hormonal effect.

What does the evidence say about sexual desire fluctuates across the menstrual cycle, peaking in the?

Sexual desire fluctuates across the menstrual cycle, peaking in the follicular and ovulatory phases, a pattern supported by multiple studies and not just cycle-tracking influencer content.

What does the evidence say about progesterone?

Progesterone is associated with reduced libido in the luteal phase, but the mechanism involves multiple hormones, and individual variation is large enough that some women report no change or the opposite effect.

What does the evidence say about persistent low libido after stopping hormonal contraceptives warrants clinical evaluation?

Persistent low libido after stopping hormonal contraceptives warrants clinical evaluation for androgen insufficiency, thyroid dysfunction, and depression, rather than an indefinite waiting period.

What does the evidence say about the 2019 global consensus position statement (davis et al., journal?

The 2019 Global Consensus Position Statement (Davis et al., Journal of Clinical Endocrinology and Metabolism) supports testosterone therapy for hypoactive sexual desire disorder in select women, but this is an off-label clinical decision, not a self-managed one.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Sophia Rudy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.